TANG CAPITAL PARTNERS LP 13D and 13G filings for Quince Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | Quince Therapeutics, Inc. QNCX | TANG CAPITAL PARTNERS LP | 3,220,000 7.500% | -400,000 (-11.05%) | Filing |
| 2023-03-31 4:00 pm Purchase | 2023-03-21 | 13G | Quince Therapeutics, Inc. QNCX | TANG CAPITAL PARTNERS LP | 3,620,000 9.980% | 3,620,000 (New Position) | Filing |